Metraipolis › archive › dc_2ea138b8070b

Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study — Europe PMC PMID:41226980

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41226980
DOI
10.3390/jcm14217583
License (as archived)
solo-consultazione
Archived
2026-11-09T01:38:11.882Z
SHA-256 of the archived text
0c5c72e82a6e06e9a75154a9e231ea271396f54c3ee4d5706e6eec296adfbc36
Stable URL of this page
https://metraipolis.com/documento/dc_2ea138b8070b

How to cite

Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study — Europe PMC PMID:41226980 — Europe PMC (en), https://europepmc.org/article/MED/41226980 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ea138b8070b (Metraipolis archive dc_2ea138b8070b, sha256 0c5c72e82a6e06e9a75154a9e231ea271396f54c3ee4d5706e6eec296adfbc36)
BibTeX
@misc{dc2ea138b8070b,
  title = {Impact of SARS-CoV-2 on Severe Asthma Patients Undergoing Biological Therapy: A Multicenter Study — Europe PMC PMID:41226980},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41226980},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ea138b8070b; sha256 0c5c72e82a6e06e9a75154a9e231ea271396f54c3ee4d5706e6eec296adfbc36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226980. Agents can read the archived copy with the MCP tool read_document.